Citations (22)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (22)
Ryota Kikuchi, Paresh P. Chothe, Xiaoyan Chu, Felix Huth, Kazuya Ishida, Naoki Ishiguro, Rongrong Jiang, Hong Shen, Simone H. Stahl, Manthena V.S. Varma, Marie‐Emilie Willemin & Bridget L. Morse. (2023) Utilization of OATP1B Biomarker Coproporphyrin‐I to Guide Drug–Drug Interaction Risk Assessment: Evaluation by the Pharmaceutical Industry. Clinical Pharmacology & Therapeutics 114:6, pages 1170-1183.
Crossref
Crossref
Paula Soria-Chacartegui, Pablo Zubiaur, Dolores Ochoa, Marcos Navares-Gómez, Houwaida Abbes, Gonzalo Villapalos-García, Alejandro de Miguel, Eva González-Iglesias, Andrea Rodríguez-Lopez, Gina Mejía-Abril, Samuel Martín-Vilchez, Sergio Luquero-Bueno, Manuel Román & Francisco Abad-Santos. (2023) Impact of Sex and Genetic Variation in Relevant Pharmacogenes on the Pharmacokinetics and Safety of Valsartan, Olmesartan and Hydrochlorothiazide. International Journal of Molecular Sciences 24:20, pages 15265.
Crossref
Crossref
Hong-Yu Luo, Li-Chen Gao, Hui-Zhi Long, Zi-Wei Zhou, Shuo-Guo Xu, Feng-Jiao Li, Hong-Li Li, Yan Cheng, Cai-Xia Li, Xing-Yu Peng, Liang Li, Ran Chen & Ping Deng. (2023) Association between the NEP rs701109 polymorphism and the clinical efficacy and safety of sacubitril/valsartan in Chinese patients with heart failure. European Journal of Clinical Pharmacology 79:5, pages 663-670.
Crossref
Crossref
Carles Vilaplana-Carnerero, Maria Giner-Soriano, Àngela Dominguez, Rosa Morros, Carles Pericas, Dolores Álamo-Junquera, Diana Toledo, Carmen Gallego, Ana Redondo & María Grau. (2023) Atherosclerosis, Cardiovascular Disease, and COVID-19: A Narrative Review. Biomedicines 11:4, pages 1206.
Crossref
Crossref
Solène Marie, Kayla L. Frost, Raymond K. Hau, Lucy Martinez-Guerrero, Jailyn M. Izu, Cassandra M. Myers, Stephen H. Wright & Nathan J. Cherrington. (2023) Predicting disruptions to drug pharmacokinetics and the risk of adverse drug reactions in non-alcoholic steatohepatitis patients. Acta Pharmaceutica Sinica B 13:1, pages 1-28.
Crossref
Crossref
Sonu Abraham, Anju Nohria, Tomas G. Neilan, Aarti Asnani, Anu Mariam Saji, Jui Shah, Tara Lech, Jason Grossman, George M. Abraham, Daniel P. McQuillen, David T. Martin, Paul E. Sax, Sourbha S. Dani & Sarju Ganatra. (2022) Cardiovascular Drug Interactions With Nirmatrelvir/Ritonavir in Patients With COVID-19. Journal of the American College of Cardiology 80:20, pages 1912-1924.
Crossref
Crossref
Makiko Shimizu, Riku Hayasaka, Yusuke Kamiya & Hiroshi Yamazaki. (2022) Trivariate Linear Regression and Machine Learning Prediction of Possible Roles of Efflux Transporters in Estimated Intestinal Permeability Values of 301 Disparate Chemicals. Biological and Pharmaceutical Bulletin 45:8, pages 1142-1157.
Crossref
Crossref
Mohammed Ahmed Akkaif, Abubakar Sha’aban, Arturo Cesaro, Ammar Ali Saleh Jaber, Andrea Vergara, Ismaeel Yunusa, Abubakar Ibrahim Jatau, Mustapha Mohammed, G. Saravana Govindasamy, Majed Ahmed Al-Mansoub, Muhamad Ali Sheikh Abdul Kader & Baharudin Ibrahim. (2022) The impact of SARS-CoV-2 treatment on the cardiovascular system: an updated review. Inflammopharmacology 30:4, pages 1143-1151.
Crossref
Crossref
Yunzhe Huang, Ran Liu, Yaqin Wang, Gege Liu, Changmao Wang, Xinyan Chen, Yuanwei Jia & Jie Shen. (2022) Evaluation of Pharmacokinetic Interactions Between the New SGLT2 Inhibitor SHR3824 and Valsartan in Healthy Chinese Volunteers. Clinical Therapeutics 44:7, pages 945-956.
Crossref
Crossref
Joo Young Na, Eunsol Yang, Jae‐Hoon Kim, In Sun Kwon, Eun‐Heui Jin, Kyung‐Sang Yu, Jinsook Kim, SeungHwan Lee & Jang Hee Hong. (2022) Comparative Pharmacokinetics Between a Fixed‐Dose Combination of Pitavastatin/Valsartan 4/160 mg and the Corresponding Individual Components Through a Partial Replicated Crossover Design in Healthy Male Subjects. Clinical Pharmacology in Drug Development 11:5, pages 615-622.
Crossref
Crossref
Nicolás R. Robles, Francesco Fici, Julian Valladares & Guido Grassi. (2021) Antiretroviral Treatment and Antihypertensive Therapy. Current Pharmaceutical Design 27:40, pages 4116-4124.
Crossref
Crossref
Gonjin Song, Jee-Eun Chung, Jeong Yee, Kyung-Eun Lee, Kyungsoo Park & Hye-Sun Gwak. (2021) Effects of SLCO1B1 and SLCO1B3 Genetic Polymorphisms on Valsartan Pharmacokinetics in Healthy Korean Volunteers. Journal of Personalized Medicine 11:9, pages 862.
Crossref
Crossref
Shubham Agarwal & Sanjeev Kumar Agarwal. (2020) Lopinavir-Ritonavir in SARS-CoV-2 Infection and Drug-Drug Interactions with Cardioactive Medications. Cardiovascular Drugs and Therapy 35:3, pages 427-440.
Crossref
Crossref
Katsiaryna Bykov, Hu Li, Sangmi Kim, Seanna M. Vine, Vincent Lo ReIIIIII & Joshua J. Gagne. (2020) Drug‐Drug Interaction Surveillance Study: Comparing Self‐Controlled Designs in Five Empirical Examples in Real‐World Data. Clinical Pharmacology & Therapeutics 109:5, pages 1353-1360.
Crossref
Crossref
Saki Noguchi, Moeko Okochi, Hayumi Atsuta, Rika Kimura, Ayaka Fukumoto, Kyoko Takahashi, Tomohiro Nishimura & Masatoshi Tomi. (2021) Substrate recognition of renally eliminated angiotensin II receptor blockers by organic anion transporter 4. Drug Metabolism and Pharmacokinetics 36, pages 100363.
Crossref
Crossref
Jingchao Sun, Wenjie Xu, Huaijie Hua, Ying Xiao, Xiaoyan Chen, Zhiwei Gao, Song Li, Xiaolong Jing, Frank Du & Guofeng Sun. (2020) Pharmacodynamic and pharmacokinetic effects of S086, a novel angiotensin receptor neprilysin inhibitor. Biomedicine & Pharmacotherapy 129, pages 110410.
Crossref
Crossref
Liang Jin, Yijun Pan, Natalie Lan Linh Tran, Leon N. Polychronopoulos, Aparna Warrier, Kim L. R. Brouwer & Joseph A. Nicolazzo. (2020) Intestinal Permeability and Oral Absorption of Selected Drugs Are Reduced in a Mouse Model of Familial Alzheimer’s Disease. Molecular Pharmaceutics 17:5, pages 1527-1537.
Crossref
Crossref
Marco Previsdomini, Elisa Graziano, Laurent Decosterd, Perrine Courlet, Andreas Perren & Alessandro Ceschi. (2019) Severe rosuvastatin accumulation with rhabdomyolysis due to drug interactions and low cardiac output syndrome. British Journal of Clinical Pharmacology 85:7, pages 1616-1618.
Crossref
Crossref
Sook Jin Seong, Boram Ohk, Woo Youl Kang, Mi-Ri Gwon, Bo Kyung Kim, Seungil Cho, Dong Heon Yang, Hae Won Lee & Young-Ran Yoon. (2019) Pharmacokinetic Drug Interactions Between Amlodipine, Valsartan, and Rosuvastatin in Healthy Volunteers. Advances in Therapy 36:7, pages 1642-1656.
Crossref
Crossref
Khondoker Alam, Alexandra Crowe, Xueying Wang, Pengyue Zhang, Kai Ding, Lang Li & Wei Yue. (2018) Regulation of Organic Anion Transporting Polypeptides (OATP) 1B1- and OATP1B3-Mediated Transport: An Updated Review in the Context of OATP-Mediated Drug-Drug Interactions. International Journal of Molecular Sciences 19:3, pages 855.
Crossref
Crossref
Saeed Chashmniam & Mohsen Tafazzoli. (2017) NMR investigation and theoretical calculations of the solvent effect on the conformation of valsartan. Journal of Molecular Structure 1148, pages 73-80.
Crossref
Crossref
Roodabeh Bahramsoltani, Roja Rahimi & Mohammad Hosein Farzaei. (2017) Pharmacokinetic interactions of curcuminoids with conventional drugs: A review. Journal of Ethnopharmacology 209, pages 1-12.
Crossref
Crossref